| # | Drug | Count |
|---|---|---|
| 0 | VALACYCLOVIR HYDROCHLORIDE | 468 |
| 1 | METHOTREXATE SODIUM | 416 |
| 2 | PREDNISONE | 396 |
| 3 | METHOTREXATE | 381 |
| 4 | ADALIMUMAB | 345 |
| 5 | OCRELIZUMAB | 255 |
| 6 | ACYCLOVIR | 251 |
| 7 | ETANERCEPT | 251 |
| 8 | DUPILUMAB | 229 |
| 9 | MYCOPHENOLATE MOFETIL | 222 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TALIMOGENE LAHERPAREPVEC | 37 | 0.0233 |
| 1 | VALACYCLOVIR HYDROCHLORIDE | 468 | 0.0065 |
| 2 | OCRELIZUMAB | 255 | 0.0041 |
| 3 | SELENIUM | 17 | 0.0040 |
| 4 | RALTEGRAVIR | 17 | 0.0032 |
| 5 | ALEMTUZUMAB | 58 | 0.0030 |
| 6 | ABACAVIR SULFATE | 29 | 0.0030 |
| 7 | FLUDARABINE PHOSPHATE | 94 | 0.0024 |
| 8 | ACYCLOVIR | 251 | 0.0022 |
| 9 | GANCICLOVIR SODIUM | 19 | 0.0018 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Macrolide Antibacterial [EPC] | 6 | 0.0059 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 58 | 0.0030 |
| 2 | Selective T Cell Costimulation Blocker [EPC] | 11 | 0.0023 |
| 3 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 253 | 0.0022 |
| 4 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 257 | 0.0022 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 453 | 0.0014 |
| 6 | Histone Deacetylase Inhibitor [EPC] | 5 | 0.0013 |
| 7 | Tetracycline-class Antibacterial [EPC] | 10 | 0.0013 |
| 8 | Ergot Derivative [EPC] | 6 | 0.0012 |
| 9 | Asparagine-specific Enzyme [EPC] | 16 | 0.0012 |